Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)

OBJECTIVE: To determine the effect of population level implementation of a test-and-treat approach to correction of suboptimal vitamin D status (25-hydroxyvitamin D (25(OH)D) <75 nmol/L) on risk of all cause acute respiratory tract infection and covid 19. DESIGN: Phase 3 open label randomised con...

Descripción completa

Detalles Bibliográficos
Autores principales: Jolliffe, David A, Holt, Hayley, Greenig, Matthew, Talaei, Mohammad, Perdek, Natalia, Pfeffer, Paul, Vivaldi, Giulia, Maltby, Sheena, Symons, Jane, Barlow, Nicola L, Normandale, Alexa, Garcha, Rajvinder, Richter, Alex G, Faustini, Sian E, Orton, Christopher, Ford, David, Lyons, Ronan A, Davies, Gwyneth A, Kee, Frank, Griffiths, Christopher J, Norrie, John, Sheikh, Aziz, Shaheen, Seif O, Relton, Clare, Martineau, Adrian R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449358/
https://www.ncbi.nlm.nih.gov/pubmed/36215226
http://dx.doi.org/10.1136/bmj-2022-071230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449358/
https://www.ncbi.nlm.nih.gov/pubmed/36215226
http://dx.doi.org/10.1136/bmj-2022-071230

Ejemplares similares